Patents by Inventor Michael P. Mortimore

Michael P. Mortimore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
    Patent number: 6555541
    Abstract: The invention provides substituted phenyl compounds of general formula wherein R1, T, U and Ar are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy.
    Type: Grant
    Filed: July 10, 2000
    Date of Patent: April 29, 2003
    Assignee: Astrazeneca UK Limited
    Inventors: Mark Furber, Timothy J Luker, Michael P Mortimore, Philip Thorne, Premji Meghani
  • Adamantane derivatives
    Patent number: 6492355
    Abstract: The invention provides compounds of general formula in which m, A, R1 and Ar have the meanings defined in the specification; a process for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: December 10, 2002
    Assignee: AstraZeneca AB
    Inventors: Lilian Alcaraz, Mark Furber, Michael P. Mortimore